Corticosteroid-resistant nephrotic syndrome with focal and segmental glomerulosclerosis : an update of treatment options for children.
Corticosteroid-resistant nephrotic syndrome (CRNS) with focal and segmental glomerulosclerosis (FSGS) is a heterogeneous disorder and the most severe and frequent type of all glomerulopathies in children leading to end-stage renal failure. The podocyte is at the center of development and progress of FSGS; this unique cell type plays a major role in the integrity of glomerular structure and permeability. The rate of complete remission of CRNS after induction therapy using different immunosuppressant agents is reported to range between 30% and 84%, depending on the treatment schedule and on the underlying defects of FSGS. Children with genetic types of FSGS barely respond to immunosuppressant therapies and over-treatment prior to transplantation should be avoided. The response of children with an idiopathic type of FSGS to immunosuppressants is superior to those with genetic FSGS. However, many children with idiopathic FSGS do not enter complete remission if they are under-treated, for example, with short-term immunosuppressant monotherapies. If immunosuppressant treatment fails, these patients will have to undergo renal transplantation. However, as unknown pathogenetic mechanisms may persist, more than one-third of these patients with idiopathic FSGS develop a rapid recurrence of CRNS that responds poorly to further long-term therapeutic attempts. In contrast with previously published data, this review takes into account recently identified genetic etiologies of CRNS, and superior results with long-term combination therapy in idiopathic forms to avoid over- and under-treatment.
Ehrich
Jochen H H
JH
Department of Pediatric Nephrology, Hannover Medical School, Hannover, Germany. ehrich.jochen@mh-hannover.de
Pape
Lars
L
Schiffer
Mario
M
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D002648:Child; D004351:Drug Resistance; D005923:Glomerulosclerosis, Focal Segmental / Q000150:complications / Q000235:genetics / Q000628:therapy*; D006801:Humans; D016030:Kidney Transplantation; D008954:Models, Biological; D009404:Nephrotic Syndrome / Q000150:complications / Q000235:genetics / Q000628:therapy*; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones